Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?

Epithelial ovarian cancer (EOC) is the leading cause of death for gynecological cancer. The standard treatment for advanced stage is the combination of optimal debulking surgery and platinum-based chemotherapy. Nevertheless, recurrence is frequent (around 70%) and prognosis is globally poor. New the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittica, Gloria, Genta, Sofia, Aglietta, Massimo, Valabrega, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964540/
https://www.ncbi.nlm.nih.gov/pubmed/27447625
http://dx.doi.org/10.3390/ijms17071169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964540/
https://www.ncbi.nlm.nih.gov/pubmed/27447625
http://dx.doi.org/10.3390/ijms17071169

Ejemplares similares